0001816514-20-000001.txt : 20200716 0001816514-20-000001.hdr.sgml : 20200716 20200716125139 ACCESSION NUMBER: 0001816514-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200716 DATE AS OF CHANGE: 20200716 EFFECTIVENESS DATE: 20200716 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Opal Biosciences, Inc. CENTRAL INDEX KEY: 0001816514 IRS NUMBER: 850692453 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-371190 FILM NUMBER: 201031222 BUSINESS ADDRESS: STREET 1: 230 PARK AVENUE, SUITE 2800 CITY: NEW YORK STATE: NY ZIP: 10169 BUSINESS PHONE: 781-367-5419 MAIL ADDRESS: STREET 1: 230 PARK AVENUE, SUITE 2800 CITY: NEW YORK STATE: NY ZIP: 10169 D 1 primary_doc.xml X0708 D LIVE 0001816514 Opal Biosciences, Inc. 230 PARK AVENUE, SUITE 2800 NEW YORK NY NEW YORK 10169 781-367-5419 DELAWARE None None Corporation true 2020 Spiros Liras c/o Opal Biosciences, Inc. 230 Park Avenue, Suite 2800 New York NY NEW YORK 10169 Executive Officer Director Seth Harrison c/o Opal Biosciences, Inc. 230 Park Avenue, Suite 2800 New York NY NEW YORK 10169 Director Michael Ehlers c/o Opal Biosciences, Inc. 230 Park Avenue, Suite 2800 New York NY NEW YORK 10169 Director James H. Doudna Cate c/o Opal Biosciences, Inc. 230 Park Avenue, Suite 2800 New York NY NEW YORK 10169 Director Rajesh Chopra c/o Opal Biosciences, Inc. 230 Park Avenue, Suite 2800 New York NY NEW YORK 10169 Director Biotechnology Decline to Disclose 06b false 2020-07-02 false true false 0 75000000 1000000 74000000 false 1 0 0 0 false Opal Biosciences, Inc. /s/ Sprios Liras Sprios Liras Chief Executive Officer 2020-07-16